| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.45 | 0.002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |